Tharimmune Stock Market Value
| THAR Stock | 4.47 0.42 10.37% |
| Symbol | Tharimmune |
Can Stock industry sustain growth momentum? Does Tharimmune have expansion opportunities? Factors like these will boost the valuation of Tharimmune. If investors know Tharimmune will grow in the future, the company's valuation will be higher. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Tharimmune demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
The market value of Tharimmune is measured differently than its book value, which is the value of Tharimmune that is recorded on the company's balance sheet. Investors also form their own opinion of Tharimmune's value that differs from its market value or its book value, called intrinsic value, which is Tharimmune's true underlying value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Because Tharimmune's market value can be influenced by many factors that don't directly affect Tharimmune's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tharimmune's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tharimmune is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Tharimmune's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Tharimmune 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Tharimmune's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Tharimmune.
| 10/31/2025 |
| 01/29/2026 |
If you would invest 0.00 in Tharimmune on October 31, 2025 and sell it all today you would earn a total of 0.00 from holding Tharimmune or generate 0.0% return on investment in Tharimmune over 90 days. Tharimmune is related to or competes with BioLineRx, GeoVax Labs, Adlai Nortye, Lunai Bioworks, SeaStar Medical, Ainos, and Apollomics. More
Tharimmune Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Tharimmune's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Tharimmune upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.51 | |||
| Information Ratio | 0.1265 | |||
| Maximum Drawdown | 35.56 | |||
| Value At Risk | (9.23) | |||
| Potential Upside | 11.15 |
Tharimmune Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Tharimmune's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Tharimmune's standard deviation. In reality, there are many statistical measures that can use Tharimmune historical prices to predict the future Tharimmune's volatility.| Risk Adjusted Performance | 0.1075 | |||
| Jensen Alpha | 0.8354 | |||
| Total Risk Alpha | 0.4157 | |||
| Sortino Ratio | 0.15 | |||
| Treynor Ratio | 1.08 |
Tharimmune January 29, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1075 | |||
| Market Risk Adjusted Performance | 1.09 | |||
| Mean Deviation | 5.14 | |||
| Semi Deviation | 4.97 | |||
| Downside Deviation | 5.51 | |||
| Coefficient Of Variation | 735.98 | |||
| Standard Deviation | 6.53 | |||
| Variance | 42.63 | |||
| Information Ratio | 0.1265 | |||
| Jensen Alpha | 0.8354 | |||
| Total Risk Alpha | 0.4157 | |||
| Sortino Ratio | 0.15 | |||
| Treynor Ratio | 1.08 | |||
| Maximum Drawdown | 35.56 | |||
| Value At Risk | (9.23) | |||
| Potential Upside | 11.15 | |||
| Downside Variance | 30.32 | |||
| Semi Variance | 24.68 | |||
| Expected Short fall | (5.90) | |||
| Skewness | 0.6461 | |||
| Kurtosis | 1.0 |
Tharimmune Backtested Returns
Tharimmune appears to be very risky, given 3 months investment horizon. Tharimmune owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.14, which indicates the firm had a 0.14 % return per unit of risk over the last 3 months. By inspecting Tharimmune's technical indicators, you can evaluate if the expected return of 0.89% is justified by implied risk. Please review Tharimmune's Coefficient Of Variation of 735.98, risk adjusted performance of 0.1075, and Semi Deviation of 4.97 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Tharimmune holds a performance score of 10. The entity has a beta of 0.81, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Tharimmune's returns are expected to increase less than the market. However, during the bear market, the loss of holding Tharimmune is expected to be smaller as well. Please check Tharimmune's value at risk, and the relationship between the jensen alpha and skewness , to make a quick decision on whether Tharimmune's existing price patterns will revert.
Auto-correlation | -0.65 |
Very good reverse predictability
Tharimmune has very good reverse predictability. Overlapping area represents the amount of predictability between Tharimmune time series from 31st of October 2025 to 15th of December 2025 and 15th of December 2025 to 29th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Tharimmune price movement. The serial correlation of -0.65 indicates that roughly 65.0% of current Tharimmune price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.65 | |
| Spearman Rank Test | -0.52 | |
| Residual Average | 0.0 | |
| Price Variance | 0.23 |
Pair Trading with Tharimmune
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Tharimmune position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tharimmune will appreciate offsetting losses from the drop in the long position's value.Moving together with Tharimmune Stock
Moving against Tharimmune Stock
| 0.63 | CSCO | Cisco Systems Aggressive Push | PairCorr |
| 0.58 | VZ | Verizon Communications Earnings Call Tomorrow | PairCorr |
| 0.4 | MPW | Medical Properties Trust | PairCorr |
| 0.4 | MRK | Merck Company Earnings Call This Week | PairCorr |
| 0.37 | MCD | McDonalds | PairCorr |
The ability to find closely correlated positions to Tharimmune could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Tharimmune when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Tharimmune - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Tharimmune to buy it.
The correlation of Tharimmune is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Tharimmune moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Tharimmune moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Tharimmune can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Tharimmune Stock Analysis
When running Tharimmune's price analysis, check to measure Tharimmune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tharimmune is operating at the current time. Most of Tharimmune's value examination focuses on studying past and present price action to predict the probability of Tharimmune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tharimmune's price. Additionally, you may evaluate how the addition of Tharimmune to your portfolios can decrease your overall portfolio volatility.